Enrique Grande, MD | Authors


IMvigor130 Shows Improvement in PFS with Atezolizumab in Metastatic Urothelial Carcinoma

October 10, 2019

Enrique Grande, MD, discusses the characteristics of metastatic urothelial cancer, which rationalizes the use of atezolizumab in combination with platinum-based chemotherapy in the IMvigor130 trial, in patients with locally advanced or metastatic urothelial carcinoma.